Inspired by these findings, the team is now moving forward with human clinical trials.
The next phase will involve 45 patients with lung can.cer or melanoma, who will take castalagin in capsule form to see how it influences their treatment outcomes.
If these trials go well, they could pave the way for a revolutionary new approach to can.cer therapy.
A Small Fruit with Enormous Potential
The implications of this research are far-reaching. If castalagin proves effective in humans, it could transform can.cer treatment and improve the outlook for countless patients around the world, all thanks to a humble berry from Brazil.
As we await the results of these trials, one thing is clear: nature continues to inspire medical innovation in remarkable ways.
The camu-camu berry is a powerful reminder that sometimes, the most extraordinary solutions come from the most unexpected sources.
